Literature DB >> 2162535

Alpha-melanocyte stimulating hormone message and inhibitory sequences: comparative structure-activity studies on melanocytes.

T K Sawyer1, D J Staples, A M Castrucci, M E Hadley, F A al-Obeidi, W L Cody, V J Hruby.   

Abstract

We investigated the structure-activity relationships of alpha-MSH (alpha-melanocyte stimulating hormone) fragment derivatives of the generic formulae Ac-alpha-MSH(x-13)-NH2 and Ac-alpha-MSH(6-x)-NH2. The minimal C-terminal sequences required for melanotropic activity were 8-13 and 7-13, respectively, in the frog and lizard skin bioassays. The Arg8-Trp9 sequence appears to be a fundamental component of the minimal message sequences found to date such as alpha-MSH(6-9), alpha-MSH(8-13) and alpha-MSH(7-13). We discovered that Ac-alpha-MSH(7-10)-NH2 was a weak and selective alpha-MSH antagonist on the lizard skin bioassay. Analysis of alpha-MSH(7-10) analogues of the generic formula Ac-Xaa-Arg-Trp-Yaa-NH2 led to Ac-[D-Trp7,D-Phe10]alpha-MSH(7-10)-NH2, a moderately potent, specific and competitive inhibitor of alpha-MSH in both the frog and the lizard skin bioassays.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2162535     DOI: 10.1016/0196-9781(90)90092-j

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  5 in total

1.  Targeted melanoma imaging and therapy with radiolabeled alpha-melanocyte stimulating hormone peptide analogues.

Authors:  T Quinn; X Zhang; Y Miao
Journal:  G Ital Dermatol Venereol       Date:  2010-04       Impact factor: 2.011

2.  Structure-based search for peptide ligands that cross-react with melanocortin receptors.

Authors:  J M Quillan; W Sadée
Journal:  Pharm Res       Date:  1996-11       Impact factor: 4.200

Review 3.  Peptide-targeted radionuclide therapy for melanoma.

Authors:  Yubin Miao; Thomas P Quinn
Journal:  Crit Rev Oncol Hematol       Date:  2008-04-02       Impact factor: 6.312

4.  The pharmacological properties of 3-arm or 4-arm DOTA constructs for conjugation to α-melanocyte-stimulating hormone analogues for melanoma imaging.

Authors:  Masato Kobayashi; Toshitaka Kato; Kohshin Washiyama; Masaaki Ihara; Asuka Mizutani; Kodai Nishi; Leo G Flores; Ryuichi Nishii; Keiichi Kawai
Journal:  PLoS One       Date:  2019-03-22       Impact factor: 3.240

5.  Milk Protein-Derived Antioxidant Tetrapeptides as Potential Hypopigmenting Agents.

Authors:  Saerom Kong; Hye-Ryung Choi; Yoon-Jeong Kim; Yoon-Sik Lee; Kyoung-Chan Park; Seon-Yeong Kwak
Journal:  Antioxidants (Basel)       Date:  2020-11-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.